[A Review of progresses in research on delayed resistance to EGFR-TKI by Traditional Chinese medicine via inhibiting cancer stem cells properties]
- 作者单位
- Affiliations 1 Basic Teaching and Research Office of Traditional Chinese Medicine, College of Integrated Traditional Chinese and Western Medicine, Jining Medical University, Jining 272067, China. 2 Department of Chest Radiotherapy, Shandong First Medical University Affiliated Cancer Hospital, Jinan 250117, China. 3 Radioimmunoassay and Molecular Imaging Laboratory, Shandong First Medical University Affiliated Cancer Hospital, Jinan 250117, China. 4 Department of Internal Medicine, Shandong First Medical University Affiliated Cancer Hospital, Jinan 250117, China. 5 Department of Integrated Traditional Chinese and Western Medicine, Shandong First Medical University Affiliated Cancer Hospital, Jinan 250117, China. *Corresponding author, E-mail: linjiamao_@12 com.
- 刊名
- Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
- 年份
- 2025
- 卷号
- Vol.41 No.1
- 页码
- 77-82
- ISSN
- 1007-8738
- 摘要
- It has been popular and challenging to undertake researches on the delay of acquired resistance of epidermal growth factor receptor tyrosine kinase inhibitors . As key cells for tumor initiation, cancer stem cells play an important role in the process of resistance to EGFR-TKI. Although preliminary studies found that traditional Chinese medicine could inhibit CSC properties and delay EGFR-TKI resistance, the specific molecular mechanism remains unclear. By summarizing the empirical syndrome tr...更多
- 文献类型
- 期刊
- 浏览量
- 2
-
被引次数
-
收录
PBU_D
Scopus